QTTB.NASDAQQ32 Bio INC

Form 4: Q32 Bio CFO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Q32 Bio Inc.'s CFO and President, Lee Kalowski, sold 3,995 shares of common stock at a weighted average price of $4.5144 to cover tax withholding obligations.

Summary

  • Lee Kalowski, CFO and President of Q32 Bio Inc. (QTTB), reported a sale of common stock.
  • A total of 3,995 shares were disposed of on February 25, 2026.
  • The shares were sold at a weighted average price of $4.5144, with individual transactions ranging from $4.35 to $4.69 per share.
  • The sale was non-discretionary and executed to cover tax withholding obligations related to the vesting of restricted stock units.
  • Following this transaction, Kalowski beneficially owns 35,943 shares of Q32 Bio Inc. common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the non-discretionary nature for tax purposes mitigates any negative sentiment typically associated with executive stock sales.

Positives

  • The sale was non-discretionary, indicating it was not a voluntary decision to reduce exposure but rather a mandatory tax-related event.

Negatives

  • A reduction in direct beneficial ownership by a key executive, even if for tax purposes, could be perceived negatively by some investors.

Future Outlook

NA

Management Comments

  • Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes are a common occurrence in executive compensation plans, particularly with the vesting of restricted stock units, and typically do not reflect a change in management's outlook on the company's prospects.

Stakeholder Impact

  • Shareholders: Minimal direct impact as it's a routine tax-related sale, not a discretionary divestment.

Key Dates

DateDescription
02/25/2026Date of transaction where 3,995 shares were disposed of.
02/27/2026Date the Form 4 was signed by the attorney-in-fact.

Recommendation

hold

The transaction is a routine, non-discretionary sale for tax purposes related to executive compensation. It does not indicate a change in the company's fundamentals or management's confidence, thus a 'hold' recommendation is appropriate as this event alone provides no new fundamental reason to buy or sell.

Keywords

Q32 Bio Inc., QTTB, Lee Kalowski, CFO, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.